Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Thirty-seven subjects (comparison group) were allocated to receive 450 mg of<br />
prednisone in 10-mg tablets over 8 days in the following manner: days 1-4, four tablets<br />
twice a day; day 5, three tablets three times a day; day 6, two tablets twice a day; day 7,<br />
one tablet twice a day; and day 8, one tablet. This group was also exposed to a sham<br />
HBOT procedure by placement in a monoplace chamber infused with seven percent<br />
oxygen at 2.8 ATA for one hour, twice a day, five days a week for a maximum of 30<br />
sessions.<br />
The remaining 42 subjects (intervention group) were given placebo tablets and were<br />
instructed to take them in the manner previously described. This group was exposed to<br />
100% oxygen in the same pressures, duration, and frequency as the comparison group.<br />
The authors report (Table 56) that total recovery from paralysis occurred in 40 of 42<br />
(95.2%; 95% CI = 88.8, 100%) patients from the intervention group compared to 28 of<br />
37 (75.7%; 95% CI = 61.8, 89.5%) patients in the comparison group. The average<br />
duration of symptoms was also shorter in the intervention group, as was the proportion<br />
found to be positive on the nerve excitability test. These results were statistically<br />
significant at the 5 percent level.<br />
Table 56 Major outcomes following treatment for facial paralysis in intervention and comparison<br />
groups (Racic et al). 92<br />
Outcome<br />
Intervention<br />
Group (n = 42)<br />
Comparison<br />
Group (n = 37)<br />
Complete recovery (n) 40 28 0.0122<br />
Average duration of symptoms (days) 22 34.4 < 0.001*<br />
Number positive on nerve excitability test (n)<br />
During course of treatment<br />
At nine months<br />
* This value is reported in the text. No standard deviations were given to allow an independent calculation of this probability.<br />
<strong>Hyperbaric</strong> oxygen therapy 57<br />
5<br />
2<br />
9<br />
9<br />
p<br />
0.1492<br />
0.0122<br />
Summary<br />
This report provided some evidence of the benefit of exposure to HBO for subjects with<br />
moderate to severe forms of facial paralysis of less than one week duration. Replication<br />
of this study to other settings and an examination of other outcomes are required to<br />
come to firm and generalisable conclusions.<br />
Sudden deafness and acoustic trauma<br />
Four studies were identified that meet inclusion criteria for this indication. A brief<br />
description of each study is given in Table 57.